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There is a recognized need for a meta-classification 
that can serve as a foundation for more refined 
ontologies in the field of proteomics. Standard data 
sources classify proteins in terms of just one or two 
specific aspects. Thus SCOP (Structural Classification 
of Proteins) is described as classifying proteins on the 
basis of structural features; SWISS-PROT annotates 
proteins on the basis of their structure and of 
parameters like post-translational modifications. Such 
data sources are connected to each other by pairwise 
term-to-term mappings. However, there are obstacles 
which stand in the way of combining them together to 
form a robust meta-classification of the needed sort. 
We discuss some formal ontological principles which 
should be taken into account within the existing 
datasources in order to make such a meta-
classification possible, taking into account also the 
Gene Ontology (GO) and its application to the 




There are a large number of existing databases and 
ontologies which classify proteins on the basis of their 
structure, function, location, evolution and so on. [1] 
When it comes to providing a complete description of 
a protein’s function, however, a wide range of factors 
needs to be taken into account, including cellular roles, 
molecular functions and the involvement of proteins in 
physiology and pathology. [2] This creates a need for 
data integration between the different proteomics 
databases, which at the moment is primarily achieved 
via pairwise term-to-term mapping between existing 
databases. This approach presumes that the databases 
to be mapped have classified proteins on the basis of 
just one or a small number of aspects. Thus for 
example the Structural Classification of Proteins 
(SCOP) is described as providing a protein 
classification on the basis of protein structure [3,4]. 
Protein Data Bank (PDB) provides a protein 
classification based on 3-D macromolecular structure 
[5,6]. In Swiss-Prot the core data consists primarily of 
sequence information, with annotations describing 
factors such as functions, post-translational 
modifications, domains and sites, and diseases 
associated with deficiencies. [7,8] At a somewhat 
different level, the Gene Ontology (GO) provides a 
large ontology of cellular components, biological 
processes and molecular functions, and serves as a de 
facto standard for annotation of gene products, 
including proteins. [9,10] However, GO has problems 
with its structure and with many of its terms, [11] and 
a robust proteomics meta-classification will require 
that such problems be resolved, not only in GO but 
also as they arise within each of the other existing 
systems.  
 
2. Structural Classification of Proteins 
 
SCOP divides proteins into the following top-level 
classes: 46456: All alpha proteins; 48274: All beta 
proteins, 51349: Alpha and beta proteins (a/b); 
53931: Alpha and beta proteins (a+b); 56572: 
Multi-domain proteins (alpha and beta); 56835: 
Membrane and cell surface proteins and peptides; 
56992 Small proteins; 57942 Coiled coil proteins; 
58117: Low resolution protein structures; 58231: 
Peptides; and 58788: Designed proteins. The SCOP 
database provides a detailed and comprehensive 
description of the structural and evolutionary 
relationships between the proteins whose structure is 
known, including all entries in the PDB, combining 
together the classifications made on the basis of 
structure and evolution.  
The major levels in the hierarchy of SCOP beneath 
class are:  
 Fold: “Major structural similarity. Proteins are 
defined as having a common fold if they have the same 
major secondary structures in the same arrangement 
and with the same topological connections. Different 
proteins with the same fold often have peripheral 
elements of secondary structure and turn regions that 
differ in size and conformation. In some cases, these 
differing peripheral regions may comprise half the 
structure. Proteins placed together in the same fold 
category may not have a common evolutionary origin: 
the structural similarities could arise just from the 
physics and chemistry of proteins favoring certain 
packing arrangements and chain topologies.”  
 Superfamily: “Probable common evolutionary 
origin Proteins that have low sequence identities, but 
whose structural and functional features suggest that a 
common evolutionary origin is probable are placed 
together in superfamilies. For example, actin, the 
ATPase domain of the heat shock protein, and 
hexakinase together form a superfamily.” 
 Family: “Clear evolutionarily relationship: 
Proteins clustered together into families are clearly 
evolutionarily related. Generally, this means that 
pairwise residue identities between the proteins are 
30% and greater. However, in some cases similar 
functions and structures provide definitive evidence of 
common descent in the absence of high sequence 
identity; for example, many globins form a family 
though some members have sequence identities of only 
15%.”  
Below family we have in addition protein, species, 
and domain. 
To test our methods we studied the the different 
membrane protein axes within SCOP and found 
problems related to the membrane and cell surface 
proteins and peptides axis. 
 
2.1. Problem of exclusion 
 
The first problem is that SCOP classifies many 
membrane proteins not within the class membrane 
and cell surface proteins and peptides, but rather 
within other classes which comprehend protein groups 
classified on the basis of their structural features. 
Examples from the version of December 2003 (SCOP 
1.65) are: 82055: Peroxisomal membrane protein, 
classified under 48724: All-beta proteins and 69907: 
Membrane penetration protein mu1, classified 
under 69907: Multi-domain proteins (alpha and 
beta). 
While these classifications may in themselves be 
correct, given the presence of a membrane and cell 
surface proteins and peptides class, they point to an 
incoherence in the underlying classificatory order. For 
they imply that we cannot infer, from: x is not a 
membrane and cell surface protein, to: x is not a 
membrane protein. When we move down the SCOP 
hierarchy through folds, superfamilies and families we 
find 219 problematic membrane protein designations at 
the level of folds, 140 and 111 further problematic 
designations at the level of superfamilies and families, 
making 470 problematic cases in all.  
 
2.2. Structure vs. location 
 
Membrane proteins constitute 36 of the 800 folds, 
66 of the 95 families and 150 of the 2327 superfamilies 
present within SCOP. The problem, for a purportedly 
structural classification of proteins like SCOP, is that 
not all membrane proteins have a common structure. 
For example, while 931 of the proteins classified 
within the axis Membrane and cell surface proteins 
and peptides have transmembrane helices, 158 of 
them do not. Indeed the question arises whether a class 
like Membrane and cell surface proteins and 
peptides should be present at all within a properly 
structural classification, or whether it would not be 
better to separate out a class labeled Proteins with 
transmembrane helices and relocate the other 
proteins classified as Membrane and cell surface 
proteins and peptides (some 14.5%) elsewhere. For 
the latter is a class that is based not on protein structure 
but rather on protein location, and it is this mixing of 
two aspects within a single classification which leads 
to the problems mentioned above. Another argument 
for a reform along these lines is that SCOP does not 
contain protein groups like ‘blood proteins’ or 
‘neuronal proteins’ and thus a class that depicts 
‘membrane proteins’ should also not be included. 
 
3. Gene Ontology and Its Annotations 
 
GO is an important tool for the representation and 
processing of gene- and gene-product-related 
information. It provides a ‘controlled vocabulary,’ 
designed to ensure that researchers in biomedicine 
should use a common terminology in reporting the 
results of their work. Gene products have been 
annotated to GO and the December 2003 version of 
GO contains over 4 million such annotations. This 
gives GO a very important position with the field of 
proteomics meta-classification.  
GO’s considerable success is testimony to the 
correctness of a number of crucial choices which were 
made by the GO Consortium in the early stages of its 
development. Above all, the adoption of a relatively 
simple architecture meant that work on populating GO 
could start immediately. Populating GO does not 
require the completion of complex protocols but can be 
done intuitively by the expert biologist, who is subject 
to few formal constraints when incorporating new 
terms.  
However, the authors of the Gene Ontology have at 
the same time ignored certain benefits of formal rigor, 
both at the level of logical relations and at the level of 
syntactic regimentation, and both in the structure of 
GO’s term hierarchies and in its definitions. The 
upshot is that there are aspects of the current 
architecture of the Gene Ontology that are predestined 
to cause ever more significant problems as GO 
increases in size. We have discussed these issues in 
detail elsewhere [11,20,32] and here we consider only 
those which are directly relevant to the issue of 
proteomics meta-classification.  
The Gene Ontology contains three orthogonal axes, 
corresponding to the three root classes Cellular 
component, Molecular function and Biological 
process.  
The cellular component ontology is GO’s 
counterpart of anatomy. It consists of terms such as 
flagellum, chromosome, ferritin, extracellular matrix 
and virion and is intended to allow biologists to 
register the physical structure with which a gene or 
gene product is associated. It includes both the 
extracellular environment of cells and the cells them-
selves (that is, cell in GO is a subclass of cellular 
component). 
GO’s molecular function ontology deals with the 
actions characteristic of gene product Molecular 
function accordingly subsumes terms describing 
actions, for example ice nucleation, binding, or protein 
stabilization, entities which do not endure but rather 
occur.  
GO’s biological process ontology comprehends 
Biological process terms can be quite specific (glyco-
lysis) or very general (death).  
 
3.1 Problems with the tripartite classification 
Molecular function and biological process terms 
are clearly closely interrelated. The process of anti-
apoptosis, for example, certainly involves the 
molecular function now labeled apoptosis inhibitor 
activity. But GO’s curators give us too little 
information is to what this relationship might be, 
suggesting only that it might be a matter of differing 
granularity: ‘A biological process is accomplished via 
one or more ordered assemblies of molecular 
functions.’ This would suggest that molecular func-
tions are constituents of biological processes, but this 
in turn would suggest also that they stand to such 
processes in a part-of relation. At the same time, 
however, GO’s authors insist that the relation part-of 
holds only within a single ontology and never between 
entities from distinct vocabulary sets.  
This leads to difficulties in automated interpretation 
of the gene product annotations. Thus we have been 
working on disease-related gene products focusing on 
annotations to GO of the genes present within
Locus_i
d 
GO_id GO_term Term_type 
1356 GO:0006811 ion transport biological_process 
1356 GO:0006825 copper ion transport biological_process 
1356 GO:0006878 copper ion homeostasis biological_process 
1356 GO:0006879 iron ion homeostasis biological_process 
1356 GO:0005507 copper ion binding molecular_function 
1356 GO:0016491 oxidoreductase activity molecular_function 
1356 GO:0004322 ferroxidase activity molecular_function 
1356 GO:0005375 copper ion transporter activity molecular_function 
1356 GO:0005615 extracellular space cellular_component 
Table 1. GO annotations for LocusID 1356: ceruloplasmin (ferroxidase) 
 
LocusLink. [13] We encounter problems in the 
interpretation of such annotations if we proceed on the 
basis of the assumption that GO’s molecular function 
and biological process axes are orthogonal. The 
LocusID 1356: ceruloplasmin (ferroxidase) 
annotations, for example, are listed in our database for 
clinical genomics models as shown in Table 1. 
Accepting GO’s assumption of orthogonality in this 
case would mean that there is no relationship between  
GO 006825: copper ion transport and GO 
0005375: copper ion transporter activity  
or between: 
GO 006878: copper ion homeostasis and GO 
0005507: copper ion binding.  
Thus if automated deductions are made on the basis of 
the orthogonality principle then this leads to loss of 
information. (For a complete list of such annotations 
related to loci annotated for colon cancer and 
colorectal cancer, see [14,15].) 
 
3.2 Problems with undefined terms 
 
Many GO terms are compositional in nature. [16] 
That is, they are built out of other terms as proper 
parts. The latter however are not always GO terms in 
their own right, and many of them are not treated, 
either, within the framework of other large 
terminology systems such as the Unified Medical 
Language System [17]. Thus, terms like ‘adult’ or 
‘evasion’, as well as operators like ‘sensu”’, ‘:’ and ‘/’ 
etc., which have not been defined explicitly in the GO 
documentation, making the interpretation of terms 
which contain the corresponding expressions difficult 
and leading to knowledge which is inaccessible to 
automatic tools for information retrieval. One 
particularly interesting example is the use of the ‘/’ 
operator, which is used within GO to represent  
 ‘and’, as in:  
  GO 0008608: microtubule/kinetochore interaction 
defined as: Physical interaction between microtubules 
and chromatin via proteins making up the kinetochore 
complex; 
 ‘or’, as in: 
GO 0001539: ciliary/flagellar motility 
defined as: Locomotion due to movement of cilia or 
flagella;  
 ‘and/or’, as in: 
GO:0045798 negative regulation of chromatin 
assembly/disassembly 
defined as: Any process that stops, prevents or reduces 
the rate of chromatin assembly and/or disassembly; 
 ‘reaction substrates and products’, as in:  
GO:0015539 hexuronate (glucuronate / 
galacturonate) porter activity 
defined as: Catalysis of the reaction: hexuronate(out) + 
cation(out) = hexuronate(in) + cation(in);  
 ‘successive reaction steps’, as in: 
GO 0000082: G1/S transition of mitotic cell cycle 
defined as: Progression from G1 phase to S phase of 
the standard mitotic cell cycle; and 
 ‘ratio’, as in:  
GO:0001559 interpretation of 
nuclear/cytoplasmic to regulate cell growth 
For a complete list of GO’s undefined terms and 
operators, see [18]. This lack of definitions and of 
rules for use of syntactic operators in the creation of 
compound terms leads to problems when GO is used 
for annotations of gene products, since such 
annotations need to be carried out by human experts 
who need to understand the meanings of the terms they 
are using. If we put together all such terms which do 
not have well-defined words or operators, they make 
2323 out of 16660 terms within the December 2003 
version of GO (13.94%). There are currently 263,632 
annotations present within GO involving these terms, 
which signifies a fraction of 6.28% of the total 
4,197,659 annotations. This is less than half of what 
one would expect if these terms were used at the same 
rate as other terms in GO, which lends support to our 
thesis that these terms not only cause difficulties for 
automatic tools but are also understood less well by 
human annotators.  
 
3.3 Problems related to part-of relations 
 
GO is structured by means of two relations, called 
‘is-a’ and ‘part-of’. We here concentrate on problems 
with the latter. On the one hand this must sometimes 
be interpreted as signifying ‘can-be-part-of’, meaning 
that A part-of B does not signify that an A term is a part 
of a B term in every case, as reflected in propositions 
such as:  
GO 0005833: hemoglobin complex part-of GO 
0005829: cytosol  
GO 0005829: cytosol part-of GO 0005737: 
cytoplasm  
GO 0005737: cytoplasm part-of GO 0005622: 
intracellular  
GO 0005634: nucleus part-of GO 0005622: cell 
GO’s new definition of ‘part-of’, however, reads in the 
terminology proposed in [19,20] as follows:  
A part-of B =: all instances of A are necessarily 
parts of instances of B. [21] 
According to this definition, hemoglobin complex 
would necessarily be part of all cells, which is of 
course not the case. GO’s inconsistent treatment of 
‘part-of’ is reflected in many errors in annotations. For 
example, 21 gene products are annotated to GO 
0005833: hemoglobin complex. These annotations 
include various chains which constitute different 
hemoglobin forms, for example hemoglobin alpha and 
beta chains. These chains, are themselves annotated for 
various hemoglobinopathies on LocusLink. By 
reasoning from GO’s treatment of hemoglobin on the 
basis of the new definition of part-of deduction, such 
hemoglobinopathies can be inferred to affect every 
cell, which would be a major error.  
Such errors within the cellular component axis are 
common. There are 36 subparts of the term GO 
0005622: intracellular none of which is present 
within all cells. One can imagine the cumulative effect 
of such ‘small errors’ if such relations are used within 
large database integrations such as those involving 
LocusLink.  
Some of these relations have been better dealt with 
in other anatomical ontologies, one of the more 
important examples being the Foundational Model of 
Anatomy [22]. For example, GO has the following 
relation: 
GO 0005634: nucleus is-part-of GO 0005622: 
intracellular 
which is dealt with in FMA as follows: 
FMA 155394: cell nucleus is-part-of FMA 
155292: protoplasm 
FMA 155292: protoplasm is-part-of FMA 
155394: nucleated cell 
FMA 154635: cytoplasm is-part-of FMA 164388: 
non-nucleated cell 
Drawing differentiations of this sort adds clarity to the 
treatment of the relation in qeustion, which in turn 
contributes to the correctness of subsequent 
deductions. Moreover, the terms which are represented 
as standing in part-of relations to other terms in GO 
usually do not have any is-a relations associated with 
them. FMA provides separate is-a and part-of relations 
for the entities within its scope. This brings further 
clarity to the FMA ontology, as illustrated for example 
by: 
FMA 155394: cell nucleus is-a FMA 146889: 
organelle, 
which means that cell nucleus is assigned in FMA to a 
type which is not recognized in GO by means of a 
separate term. 
 
3.4 Problems with ‘sensu’ 
 
A related set of problems can be illustrated by 
examining GO’s use of its ‘sensu’ operator, which is 
introduced to cope with those cases where a word or 
phrase has different meanings when applied to 
different organisms. Consider for example the case of 
GO 0005618: cell wall, whose subclasses include GO 
0009274: cell wall (sensu bacteria) and GO 0009277: 
cell wall (sensu Fungi), the latter being introduced in 
reflection of the fact that cell walls in bacteria and 
fungi have a completely different composition from 
cell walls in most other types of organisms. As the GO 
documentation has it: ‘Using the sensu reference 
makes the node available to other species that use the 
same process/function/component’. [23] The problem 
is however that, if ‘sensu’ is indeed designed to 
indicate that the modified term refers to a different 
class from that to which the unmodified term refers, 
then in what sense are we still dealing with ‘the same 
process/function/component’? 
Since the primary goal of the GO Consortium is to 
provide an ontology of gene products applicable to all 
species, they insist that sensu terms be introduced 
sparingly. In consequence, sensu terms are allowed to 
have non-sensu terms as children, as in 
GO 0000326: protein storage vacuole is-a GO 
0000325: vacuole (sensu Streptophyta) 
This, however, is to imply that protein storage 
vacuoles occur only in Streptophyta, which is to ignore 
for example the existence of fungal protein storage 
vacuoles. (This case has been reported as an error to 
GO’s SourceForge tracker.)  
In all 79 out of 469 (16.84%) of GO sensu terms 
are subject to errors of this kind. A particularly 
intriguing example, which also illustrates GO’s 
inconsistent handling of the relation of localization, is 
GO’s postulation of: 
GO 0005934: bud tip is-a GO 0000134: site of 
polarized growth (sensu Saccharomyces) 
What this means is that every instance of bud tip in 
every organism has an instance of Saccharomyces 
polarized growth located therein. 
Another problematic example pertains to GO 
0045500: R7 differentiation, for which GO asserts: 
GO 454666: R7 differentiation is a GO 0001751: 
eye photoreceptor differentiation (sensu 
Drosophilia) 
For again, there is R7 differentiation in species other 
than Drosophilia, for example in crustaceans. 
A further problem is caused by GO’s use of ‘sensu 
Invertebrata’. Whereas vertebrate is a well-defined 
biological taxon, biologists tend to disagree on what 
the definition of invertebrate should be, and thus apply 
the ‘sensu Invertebrata’ modifier to different taxa. The 
resultant errors are illustrated for example in the genes 
annotated to 
GO 0006960: antimicrobial humoral response 
(sensu Invertebrata) 
many of which are not invertebrate genes but rather 
human genes (for example COPE HUMAN, PTGE 
HUMAN, PTE1 HUMAN, and so on). It is surely 
obvious that a gene with suffix ‘HUMAN’ should not 
be annotated to a biological process which is assigned 
to invertebrates.  
In addition, there are some 25 cases where sensu 
terms are listed by GO as synonyms of non-sensu 
terms, which seems to contravene GO’s own stated 
rationale for the introduction of the sensu operator. 
Note that a term of the form ‘X (sensu Y)’ should not 
be taken to refer only to those instances of the class X 
which occur only in species Y. Rather it takes the form 
of an instruction: use the term ‘X’ in the way this term 
is used by people working on species Y.  
Jane Lomax (personal communication) has pointed 
out that sensu was originally created to distinguish 
identical text strings with different meanings: an early 
example was ‘mating’ in mouse and in yeast. By 
adding ‘sensu’, the idea was not to exclude certain taxa 
from using a sensu term, but rather to give a user an 
idea of what sense a term should be used in. For 
example, if another flying insect were to be annotated 
to GO, we would hope that the ‘sensu Drosophila’ 
terms could be used for this new species. 
 
3.4 Problems with synonyms 
 
GO has within its December 2003 edition some 
4740 synonyms for its 16660 terms, many terms 
having more than one synonyms. Such a large 
percentage of terms (3570 distinct terms, 21.43%) with 
synonyms implies that one needs to be rigorous in 
determining if the synonyms of the terms are correct. 
There are many different errors which one finds within 
GO’s synonyms, some of them are as follows: 
a. Cases where a term and a subordinate term are 
treated as synonyms, for example: 
GO 0004601: peroxidase activity has synonyms 
lactoperoxidase activity and myeloperoxidase 
activity 
b. Cases where terms for an activity and its bearer are 
made synonyms (this seems to be the commonest type 
of error): 
GO 0005344: oxygen transport activity has 
synonyms hemoerythrin and hemocyanin 
GO 0004907: interleukin receptor activity has 
synonym IL receptor 
GO 0003823: antigen binding has synonym 
antibody 
c. Cases where terms for events occurring in sequence 
are treated as synonyms: 
GO associative learning has synonyms 
conditional learning and conditional response 
d. Cases where terms for location and content are 
treated as synonyms: 
GO 0042597: periplasmic space has synonym 
periplasm 
e. Cases where terms can be treated as synonyms only 
in relation to a specific group of cases: 
GO 0005803: secretory vescicle has synonym 
transport vescicle 
f. Cases where a ‘sensu’ term has a synonym which is 
not specific for that particular species 
GO 0012511: lipid storage body (sensu 
Viridiplantae) has synonyms oil body, oleosome, 
spherosome and GO: 0009520 
g. Cases where synonyms are term IDs when those IDs 
do not map to any further term. (For example under f., 
GO: 0009520 is considered a synonym of the other 
terms mentioned.) 
Some, at least, of these problems are to a degree 
ameliorated if one recognizes that GO means 
something very special by ‘synonym’, which despite 
their name, “are not always exactly synonymous to the 
term they are attached to. This is because it is often 
useful to search on a string related to the term of 
interest, for example, if I search GO for ‘respiration’ I 
retrieve two terms, ‘respiratory gaseous exchange; 
GO:0007585’ and ‘cellular respiration; GO:0045333’ 
which I can choose between, although respiration is 
not directly synonymous with either term. Equally, it is 
also useful to include exactly synonymous terms and 
very loosely related terms such as individual gene 
products, so there is actually a spectrum of 





SWISS-PROT is a curated protein sequence database 
which provides descriptions of proteins and 
annotations to a variety of further types of data and is 
integrated with over 60 proteomics and protein-related 
databases.  
There are two types of data present within SWISS-
PROT – core data, which consists of sequence data 
together with citation information and taxonomic data 
(descriptions of the biological source of the protein); 
and annotation data, which pertains to the functions of 
the protein and post-translational modifications (for 
example carbohydrates, phosphorylation, acetylation, 
GPI-anchor, etc.), domains and sites (for example 
calcium binding regions, ATP-binding sites, zinc 
fingers, homeobox, kringle, etc.); secondary structure, 
quaternary structure (for example homodimer, 
heterotrimer, etc.), similarities to other proteins, 
disease(s) associated with deficiencie(s) in the protein, 
sequence conflicts, variants, etc. 
SWISS-PROT affirms that, “the core data is well 
mapped, [but] there are problems with some of the 
annotation data, especially those which are put within 
‘Comments’ and are usually free text.” 
The headings used to organize annotation data 
consist of: allergen, alternative products, 
biotechnology, catalytic activity, caution, cofactor, 
database, developmental stage, disease, domain, en-
zyme regulation, function, induction, mass spectro-
metry, miscellaneous, pathway, pharmaceutical, 
polymorphism, posttranslational modification, 
RNA editing, similarity, subcellular location and 
tissue specificity. 
 
4.1 Problems with comments 
 
In order to determine the sorts of problems which 
might associated with the task of integrating its 
annotation information, we investigated the comments 
included in SWISS-PROT with respect to GO:  
SWISS-PROT: induction has 59 non-obsolete GO 
counterparts including GO 0001759: induction of an 
organ, GO 0006917: induction of apoptosis. Since 
the annotation component of SWISS-PROT and GO 
seem to be complementary, and since GO’s has the 
more elaborate structure, it is interesting to investigate 
how far we can map from SWISS-PROT to the 
terminology and classification of GO.  
Considering SWISS-PROT: catalytic activity, 
SWISS-PROT: enzyme regulation, SWISS-PROT: 
function, SWISS-PROT: induction and SWISS-
PROT pathway, almost all of them fall within GO’s 
biological process or molecular function axes.  
GO 003824: catalytic activity is classified within 
the molecular function axis. 36 other non-obsolete 
GO terms containing ‘catalysis’ or related grammatical 
forms are divided between this axis (16) and the 
biological process (13) and cellular component (7) 
axes. There are 1305 non-obsolete GO terms which 
contain the word ‘regulation’ or related grammatical 
forms, all of which fall within the biological process 
axis. There 4 are non-obsolete GO terms which contain 
the word ‘function’, all of which fall within the 
molecular function axis. Among the 59 terms 
containing ‘induction’ or related grammatical forms 
mentioned above, 54 belong to biological process, 4 to 
molecular function and 1 to the cellular component 
axis. SWISS-PROT pathway can be related to GO 
terms containing ‘pathway’ or related forms (170 
within biological process only for ‘pathway’ and 192 
including related forms, 6 within molecular function 
and 1 within cellular component axes), or to terms 
containing ‘cycle’ (86 within biological process and 3 
within cellular component axes).  
In any case, therefore, a mapping from SWISS-
PROT annotations to the corresponding GO terms will 
be tangled indeed. This also adds weight to our thesis 
that GO’s biological process and molecular function 
axes are not orthogonal. [11] 
 
4.2 Problems related to subcellular location 
annotations 
 
SWISS-PROT annotates subcellular location for its 
proteins, while GO’s cellular component axis has its 
own annotations for subcellular locations. These two 
systems of annotations have not been synchronized, 
and it seems that GO’s cellular component axis has 
more annotations than are to be found within SWISS-
PROT. This might be due to the Gene Ontology 
Annotation (GOA) project, which aims to apply GO’s 
vocabulary to a non-redundant set of proteins 
described in the UniProt Resource (Swiss-
Prot/TrEMBL/PIR-PSD) and Ensembl databases that 
collectively provide complete proteomes for Homo 
sapiens and other organisms. [25] It would be useful if 
SWISS-PROT’s data were synchronized with this 
GOA data. In light of the problems with GO’s 
treatment of location, however, such a synchronization 
will only be a first step towards representation of 
location for proteins. For example, 
SWISS-PROT annotates the subcellular location of 
SWISS-PROT CCHL_HUMAN P53701: cytochrome 
c-type heme lyase to: mitochondrial inner 
membrane. GO, on the other hand, links the same 
protein with GO 0005758: mitochondrial 
intermembrane space (defined as ‘The space between 
the mitochondrial outer membrane and inner 
membrane’) and also with GO 0005743: 
mitochondrial inner membrane, both of which are 
described as part-of GO 0005735: mitochondrion. 
Comparing the two annotations, we can find SWISS-
PROT as having a less compete coverage than GOA.  
To take matters further, Lill et al have specified the 
protein to be ‘bound to mitochondrial inner membrane 
and located within the intermembrane space’. [26] 
GO’s cellular component axis does not have relations 
of the type ‘is-bound-to’ or ‘is-located-in’. This means 
that there is still unclaimed knowledge within the 
medical text which can not be accounted by GO’s 
annotations, especially when ‘boundedness’ or 
‘location’ to a subcellular location has implications 
regarding protein’s 3D structure and posttranslational 
modifications and is well-documented within SWISS-




There are a number of reasons why the first steps 
towards proteomics meta-classification must be taken 
manually: 
1. Use of different classificatory aspects rests on tacit 
specialist knowledge, and there is no automated 
method to derive the latter. 
2. Is-a and part-of relations have been employed in 
inconsistent ways. 
3. Some relationships can be verified automatically; 
but where (for example in SCOP’s treatment of 
membrane proteins) entities have been classified in a 
way which hinders meta-classification, one needs to 
modify the relations manually. 
Broadly speaking, such problems exist with most, if 
not all biomedical ontologies and classifications, and a 
fundamental review is needed in order to address the 
pertinent issues. [11,16,19,20,27] Pragmatic principles 
have led to the creation of relatively simple models and 
this has facilitated the storage of large amounts of 
biomedical data within a reasonably short period of 
time by biologists and biomedical researchers. In the 
next era, adherence to formal principles of 
representation would help make such data better 
manageable, and this in turn would contribute to more 
robust bioinformatic science. 
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